Literature DB >> 31840390

Risk prediction scores for acute on chronic liver failure development and mortality.

Nadim Mahmud1,2, Rebecca A Hubbard3, David E Kaplan1,4, Tamar H Taddei5,6, David S Goldberg7.   

Abstract

BACKGROUND & AIMS: Acute on chronic liver failure (ACLF) causes high short-term mortality in patients with previously stable chronic liver disease. To date there are no models to predict which patients are likely to develop ACLF, and existing models to predict ACLF mortality are based on limited cohorts. We sought to create novel risk prediction scores using a large cohort of patients with cirrhosis.
METHODS: We performed a retrospective cohort study of 74 790 patients with incident cirrhosis in the Veterans Health Administration database using randomized 70% derivation/30% validation sets. ACLF events were identified per the European ACLF criteria. Multivariable logistic regression was used to derive prediction models for developing ACLF at 3, 6 and 12 months, and ACLF mortality at 28 and 90 days. Mortality models were compared to model for end-stage liver disease (MELD), MELD-sodium and the Chronic Liver Failure Consortium (CLIF-C) ACLF score.
RESULTS: Models for the developing ACLF had very good discrimination (concordance [C] statistics 0.83-0.87) at all timepoints. Models for ACLF mortality also had good discrimination at 28 and 90 days (C-statistics 0.79-0.82), and were superior to MELD, MELD-sodium and the CLIF-C ACLF score. The calibration of the novel models was excellent at all timepoints.
CONCLUSION: We have obtained highly-predictive models for developing ACLF, as well as for ACLF short-term mortality in a diverse United States cohort. These may be used to identify outpatients at significant risk of ACLF, which may prompt closer follow-up or early transplant referral, and facilitate decision making for patients with diagnosed ACLF, including escalation of care, expedited transplant evaluation or palliation.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  European Association for the Study of the Liver (EASL); chronic liver disease; cirrhosis; prediction modeling

Mesh:

Year:  2019        PMID: 31840390      PMCID: PMC7371261          DOI: 10.1111/liv.14328

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  37 in total

1.  Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014.

Authors:  Shiv Kumar Sarin; Chandan Kumar Kedarisetty; Zaigham Abbas; Deepak Amarapurkar; Chhagan Bihari; Albert C Chan; Yogesh Kumar Chawla; A Kadir Dokmeci; Hitendra Garg; Hasmik Ghazinyan; Saeed Hamid; Dong Joon Kim; Piyawat Komolmit; Suman Lata; Guan Huei Lee; Laurentius A Lesmana; Mamun Mahtab; Rakhi Maiwall; Richard Moreau; Qin Ning; Viniyendra Pamecha; Diana Alcantara Payawal; Archana Rastogi; Salimur Rahman; Mohamed Rela; Anoop Saraya; Didier Samuel; Vivek Saraswat; Samir Shah; Gamal Shiha; Brajesh Chander Sharma; Manoj Kumar Sharma; Kapil Sharma; Amna Subhan Butt; Soek Siam Tan; Chitranshu Vashishtha; Zeeshan Ahmed Wani; Man-Fung Yuen; Osamu Yokosuka
Journal:  Hepatol Int       Date:  2014-09-26       Impact factor: 6.047

2.  A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models.

Authors:  Evangelia Christodoulou; Jie Ma; Gary S Collins; Ewout W Steyerberg; Jan Y Verbakel; Ben Van Calster
Journal:  J Clin Epidemiol       Date:  2019-02-11       Impact factor: 6.437

3.  Standardizing the power of the Hosmer-Lemeshow goodness of fit test in large data sets.

Authors:  Prabasaj Paul; Michael L Pennell; Stanley Lemeshow
Journal:  Stat Med       Date:  2012-07-26       Impact factor: 2.373

4.  Association of Provider Specialty and Multidisciplinary Care With Hepatocellular Carcinoma Treatment and Mortality.

Authors:  Marina Serper; Tamar H Taddei; Rajni Mehta; Kathryn D'Addeo; Feng Dai; Ayse Aytaman; Michelle Baytarian; Rena Fox; Kristel Hunt; David S Goldberg; Adriana Valderrama; David E Kaplan
Journal:  Gastroenterology       Date:  2017-03-07       Impact factor: 22.682

5.  Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.

Authors:  Richard Moreau; Rajiv Jalan; Pere Gines; Marco Pavesi; Paolo Angeli; Juan Cordoba; Francois Durand; Thierry Gustot; Faouzi Saliba; Marco Domenicali; Alexander Gerbes; Julia Wendon; Carlo Alessandria; Wim Laleman; Stefan Zeuzem; Jonel Trebicka; Mauro Bernardi; Vicente Arroyo
Journal:  Gastroenterology       Date:  2013-03-06       Impact factor: 22.682

6.  Association of distance from a transplant center with access to waitlist placement, receipt of liver transplantation, and survival among US veterans.

Authors:  David S Goldberg; Benjamin French; Kimberly A Forde; Peter W Groeneveld; Therese Bittermann; Lisa Backus; Scott D Halpern; David E Kaplan
Journal:  JAMA       Date:  2014-03-26       Impact factor: 56.272

7.  Grade 1 Acute on Chronic Liver Failure Is a Predictor for Subsequent Grade 3 Failure.

Authors:  Nadim Mahmud; Vinay Sundaram; David E Kaplan; Tamar H Taddei; David S Goldberg
Journal:  Hepatology       Date:  2020-04-03       Impact factor: 17.425

8.  Prevalence and short-term mortality of acute-on-chronic liver failure: A national cohort study from the USA.

Authors:  Ruben Hernaez; Jennifer R Kramer; Yan Liu; Aylin Tansel; Yamini Natarajan; Khozema B Hussain; Pere Ginès; Elsa Solà; Richard Moreau; Alexander Gerbes; Hashem B El-Serag; Fasiha Kanwal
Journal:  J Hepatol       Date:  2018-12-25       Impact factor: 25.083

Review 9.  Acute-on-chronic liver failure: an update.

Authors:  Ruben Hernaez; Elsa Solà; Richard Moreau; Pere Ginès
Journal:  Gut       Date:  2017-01-04       Impact factor: 23.059

10.  Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study.

Authors:  Elliot B Tapper; Neehar D Parikh
Journal:  BMJ       Date:  2018-07-18
View more
  8 in total

1.  External Validation of the FIPS Score for Post-TIPS Mortality in a National Veterans Affairs Cohort.

Authors:  Sara E Chapin; David S Goldberg; David E Kaplan; Nadim Mahmud
Journal:  Dig Dis Sci       Date:  2021-11-19       Impact factor: 3.487

2.  Models for acute on chronic liver failure development and mortality in a veterans affairs cohort.

Authors:  Karen Y Xiao; Rebecca A Hubbard; David E Kaplan; Tamar H Taddei; David S Goldberg; Nadim Mahmud
Journal:  Hepatol Int       Date:  2020-06-09       Impact factor: 6.047

3.  Patient Frailty Is Independently Associated With the Risk of Hospitalization for Acute-on-Chronic Liver Failure.

Authors:  Shivani Shah; David S Goldberg; David E Kaplan; Vinay Sundaram; Tamar H Taddei; Nadim Mahmud
Journal:  Liver Transpl       Date:  2020-10-28       Impact factor: 5.799

4.  Accurate long-term prediction of death for patients with cirrhosis.

Authors:  David Goldberg; Alejandro Mantero; David Kaplan; Cindy Delgado; Binu John; Nadine Nuchovich; Ezekiel Emanuel; Peter P Reese
Journal:  Hepatology       Date:  2022-04-01       Impact factor: 17.298

5.  Statin exposure is associated with reduced development of acute-on-chronic liver failure in a Veterans Affairs cohort.

Authors:  Nadim Mahmud; Sara Chapin; David S Goldberg; K Rajender Reddy; Tamar H Taddei; David E Kaplan
Journal:  J Hepatol       Date:  2022-01-21       Impact factor: 30.083

6.  Early Transplantation in Acute on Chronic Liver Failure: Who and When.

Authors:  Nadim Mahmud; Ruben Hernaez; Tiffany Wu; Vinay Sundaram
Journal:  Curr Hepatol Rep       Date:  2020-06-18

7.  Development, Validation, and Evaluation of a Simple Machine Learning Model to Predict Cirrhosis Mortality.

Authors:  Fasiha Kanwal; Thomas J Taylor; Jennifer R Kramer; Yumei Cao; Donna Smith; Allen L Gifford; Hashem B El-Serag; Aanand D Naik; Steven M Asch
Journal:  JAMA Netw Open       Date:  2020-11-02

8.  The Predictive Role of Model for End-Stage Liver Disease-Lactate and Lactate Clearance for In-Hospital Mortality Among a National Cirrhosis Cohort.

Authors:  Nadim Mahmud; Sumeet K Asrani; David E Kaplan; Gerald O Ogola; Tamar H Taddei; Patrick S Kamath; Marina Serper
Journal:  Liver Transpl       Date:  2020-12-09       Impact factor: 5.799

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.